Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
about
Targeting the mTOR signaling pathway in neuroendocrine tumorsAdvances in the treatment of relapsed or refractory Hodgkin's lymphomaSummary of emerging personalized medicine in neuroendocrine tumors: are we on track?Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advancesA case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus.Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesEverolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Metastatic Insulinoma Following Resection of Nonsecreting Pancreatic Islet Cell Tumor: A Case Report and Review of the Literature.Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.The treatment of hyperinsulinemic hypoglycaemia in adults: an update.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?Intermittent everolimus administration for malignant insulinoma.Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease.Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia.Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma.Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model.Management of functional neuroendocrine tumors of the pancreas.IGF2-induced hypoglycemia unresponsive to everolimus.Everolimus Directly Suppresses Insulin Secretion Independently of Cell Growth Inhibition.
P2860
Q26852089-1265D33E-A9B1-4B9C-9921-2220B0CB5F14Q27694504-14380AB9-2379-4417-8E4A-32C332FA79DBQ28078610-DD18629D-0CB1-4A89-9C14-23A1BBB03AE3Q34650411-37F83477-5B88-424A-B761-96DFA0D0C17EQ36877057-580E434F-C5B0-4D56-97C1-EE0EA2F67B5CQ37000488-5B3D4B45-1778-4CF4-B1C0-04E61F48CA03Q37125550-43373DF2-B64F-4D0D-ACCF-04C7FFC1E66AQ37190310-F55EE8F0-E2F2-42E9-B7B7-49A1B8E221BCQ38123696-A4FF8341-3459-4470-BD98-5ED5A3C85D8CQ38596493-9361FCC8-12AD-4FA4-BD22-B681A7CE41C1Q38730927-3CAE5602-88B1-4D19-8A8B-A5B9BD0F9415Q38953515-9C975E54-3D6F-47BF-B8B6-F707568E4FA4Q38956091-C26C72F4-3539-418B-9554-F66FEFF380C7Q39156308-A9B77485-38A7-42C6-B198-3CB9C90B84DFQ41863020-C19268D0-12EF-460A-9B68-1422158D84FCQ42411399-57A89765-6FDF-467A-B4E1-0454C7E2FF99Q44779570-A2AC84D0-BAE9-49CD-B84F-9B0C2B5DAB51Q50016800-5CDB4F7E-FA45-4012-BE72-1F6E89801DF6Q51606652-E467145E-DA0C-4A81-AE47-AF4454B722DBQ52599451-F8B52490-ACCD-43EE-B7FA-276DB1D72577Q53185648-65B43419-210C-4DE4-A209-E1012F892025Q55297816-15039AA0-5886-42C6-8B78-76A2DA8284DE
P2860
Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@ast
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@en
type
label
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@ast
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@en
prefLabel
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@ast
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@en
P2093
P2860
P1433
P1476
Everolimus induces rapid plasm ...... mor as well as normal tissues.
@en
P2093
Adrienne H Brouwers
Elisabeth G E de Vries
Ester J M Siemerink
Geke A P Hospers
Helle-Brit Fiebrich
Thera P Links
Wouter S Remkes
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0222
P577
2011-04-11T00:00:00Z